{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:53:48Z","timestamp":1786992828891,"version":"build-2736575974"},"reference-count":108,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jiph.2025.102840","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:59:47Z","timestamp":1748084387000},"page":"102840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The potential role of probiotics and their bioactive compounds in the management of pulmonary tuberculosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Hamed","family":"Memariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4964-3117","authenticated-orcid":false,"given":"Mojtaba","family":"Memariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ebrahim","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolmajid","family":"Ghasemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Nour Neamatollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijtb.2020.02.005","article-title":"A systemic review on tuberculosis","volume":"67","author":"Natarajan","year":"2020","journal-title":"Indian J Tube"},{"issue":"9","key":"10.1016\/j.jiph.2025.102840_bib2","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230859","article-title":"A half-century of research on tuberculosis: Successes and challenges","volume":"220","author":"Bloom","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jiph.2025.102840_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15212\/ZOONOSES-2021-0021","article-title":"Global control of tuberculosis: current status and future prospects","volume":"2","author":"Huang","year":"2022","journal-title":"Zoonoses"},{"issue":"5","key":"10.1016\/j.jiph.2025.102840_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.medcli.2024.02.030","article-title":"Update on the treatment of tuberculosis","volume":"163","author":"Mart\u00ednez-Campreci\u00f3s","year":"2024","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"10.1016\/j.jiph.2025.102840_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00180-19","article-title":"The changing paradigm of drug-resistant tuberculosis treatment: successes, pitfalls, and future perspectives","volume":"35","author":"Dookie","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiph.2025.102840_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s12602-025-10455-z","article-title":"New frontiers in fighting mycobacterial Infections: Venom-derived peptides","author":"Memariani","year":"2025","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.jiph.2025.102840_bib7","unstructured":"World Health Organization (WHO), Global tuberculosis report 2024. Accessed January 17, 2025: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024."},{"key":"10.1016\/j.jiph.2025.102840_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944183","article-title":"Progressive host-directed strategies to potentiate BCG vaccination against tuberculosis","volume":"13","author":"Negi","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The innate immune response to Mycobacterium tuberculosis infection","volume":"39","author":"Ravesloot-Ch\u00e1vez","year":"2021","journal-title":"Annu Rev Immunol"},{"issue":"102","key":"10.1016\/j.jiph.2025.102840_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado5951","article-title":"Immunopathology in human tuberculosis","volume":"9","author":"Scriba","year":"2024","journal-title":"Sci Immunol"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib11","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s00210-024-03466-0","article-title":"Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape","volume":"398","author":"Patel","year":"2025","journal-title":"Naunyn Schmiede Arch Pharm"},{"key":"10.1016\/j.jiph.2025.102840_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.724033","article-title":"Gut microbiota modulation as a potential target for the treatment of lung infections","volume":"12","author":"Cruz","year":"2021","journal-title":"Front Pharm"},{"key":"10.1016\/j.jiph.2025.102840_bib13","series-title":"Fungi Biol Control Syst","first-page":"161","article-title":"Mycoparasitism and plant disease control","author":"Whipps","year":"1988"},{"key":"10.1016\/j.jiph.2025.102840_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg","year":"2020","journal-title":"Microbiome"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib15","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0111","article-title":"The gut microbiome: a core regulator of metabolism","volume":"256","author":"Fujisaka","year":"2023","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.jiph.2025.102840_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.trsl.2012.05.003","article-title":"The human gut microbiome: current knowledge, challenges, and future directions","volume":"160","author":"Dave","year":"2012","journal-title":"Transl Res"},{"issue":"9","key":"10.1016\/j.jiph.2025.102840_bib17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1080\/10408398.2016.1269054","article-title":"Impact of human aging and modern lifestyle on gut microbiota","volume":"58","author":"Valle Gottlieb","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jiph.2025.102840_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1225120","article-title":"Exploring the gut microbiota: lifestyle choices, disease associations, and personal genomics","volume":"10","author":"Pedroza Matute","year":"2023","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard","year":"2017","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41672","article-title":"New horizons in the treatment of psoriasis: Modulation of gut microbiome","volume":"11","author":"Memariani","year":"2025","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.jiph.2025.102840_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41435-021-00126-8","article-title":"The aging gut microbiome and its impact on host immunity","volume":"22","author":"Bosco","year":"2021","journal-title":"Genes Immun"},{"issue":"10","key":"10.1016\/j.jiph.2025.102840_bib22","first-page":"1279","article-title":"The Influence of the gut microbiota on host health: a focus on the gut\u2013lung axis and therapeutic approaches","volume":"14","author":"Alswat","year":"2024","journal-title":"Life 2024"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41385-020-00365-4","article-title":"Introduction to host microbiome symbiosis in health and disease","volume":"14","author":"Malard","year":"2021","journal-title":"Mucosal Immunol"},{"issue":"7","key":"10.1016\/j.jiph.2025.102840_bib24","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.3390\/ijms25074051","article-title":"Microbiota and immunity during respiratory infections: lung and gut affair","volume":"25","author":"Marrella","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiph.2025.102840_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1237998","article-title":"The microbiome and the gut-lung axis in tuberculosis: interplay in the course of disease and treatment","volume":"14","author":"Alvarado-Pe\u00f1a","year":"2023","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.jiph.2025.102840_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","article-title":"Microbes, metabolites, and the gut\u2013lung axis","volume":"12","author":"Dang","year":"2019","journal-title":"Mucosal Immunol"},{"issue":"22","key":"10.1016\/j.jiph.2025.102840_bib27","doi-asserted-by":"crossref","first-page":"12220","DOI":"10.3390\/ijerph182212220","article-title":"The role of gut and lung microbiota in susceptibility to tuberculosis","volume":"18","author":"Comberiati","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jiph.2025.102840_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1149679","article-title":"The gut microbiome: A line of defense against tuberculosis development","volume":"13","author":"Yu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiph.2025.102840_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3389\/fphys.2017.00822","article-title":"Alternation of gut microbiota in patients with pulmonary tuberculosis","volume":"8","author":"Luo","year":"2017","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245534","article-title":"Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting","volume":"16","author":"Khaliq","year":"2021","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.jiph.2025.102840_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008230","article-title":"Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota","volume":"14","author":"Namasivayam","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jiph.2025.102840_bib32","article-title":"Alterations in the gut microbiome of individuals with tuberculosis of different disease states","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/1751-7915.13761","article-title":"Characteristic gut microbiota and metabolic changes in patients with pulmonary tuberculosis","volume":"15","author":"Wang","year":"2022","journal-title":"Micro Biotechnol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/1462-2920.14015","article-title":"Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers","volume":"20","author":"Maji","year":"2018","journal-title":"Environ Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12887-019-1782-2","article-title":"Characterization of gut microbiota in children with pulmonary tuberculosis","volume":"19","author":"Li","year":"2019","journal-title":"BMC Pedia"},{"key":"10.1016\/j.jiph.2025.102840_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijid.2021.08.064","article-title":"Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study","volume":"111","author":"Shi","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2025.102840_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103374","article-title":"Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis","volume":"67","author":"Naidoo","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00615-21","article-title":"Gut mycobiota dysbiosis in pulmonary tuberculosis patients undergoing anti-tuberculosis treatment","volume":"9","author":"Cao","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116291","article-title":"The characteristics of the gut microbiota in patients with pulmonary tuberculosis: A systematic review","volume":"109","author":"Li","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2025.102840_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14787210.2023.2162879","article-title":"Impact of tuberculosis disease on human gut microbiota: a systematic review","volume":"21","author":"Baral","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiph.2025.102840_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2466-13-23","article-title":"Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis","volume":"13","author":"Mily","year":"2013","journal-title":"BMC Pulm Med"},{"issue":"7","key":"10.1016\/j.jiph.2025.102840_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005007","article-title":"Phenylbutyrate is bacteriostatic against Mycobacterium tuberculosis and regulates the macrophage response to infection, synergistically with 25-hydroxy-vitamin D\u2083","volume":"11","author":"Coussens","year":"2015","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/joim.12767","article-title":"Daily adjunctive therapy with vitamin D 3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia","volume":"284","author":"Bekele","year":"2018","journal-title":"J Intern Med"},{"issue":"9","key":"10.1016\/j.jiph.2025.102840_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138340","article-title":"Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial","volume":"10","author":"Mily","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jiph.2025.102840_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12879-018-3203-9","article-title":"Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy","volume":"18","author":"Rekha","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"13","key":"10.1016\/j.jiph.2025.102840_bib46","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1021\/acsomega.3c05846","article-title":"Short-chain fatty acid (SCFA) as a connecting link between microbiota and gut-lung axis\u2500 a potential therapeutic intervention to improve lung health","volume":"9","author":"Verma","year":"2024","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.jiph.2025.102840_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00188-21","article-title":"Short-chain fatty acids as a potential treatment for infections: a closer look at the lungs","volume":"89","author":"Machado","year":"2021","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.jiph.2025.102840_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jinf.2018.08.006","article-title":"Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs","volume":"78","author":"Hu","year":"2019","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.jiph.2025.102840_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/microorganisms12020234","article-title":"The potential impact of probiotics on human health: An update on their health-promoting properties","volume":"12","author":"Maftei","year":"2024","journal-title":"Microorganisms"},{"issue":"47","key":"10.1016\/j.jiph.2025.102840_bib50","first-page":"1260","article-title":"Kollath W. The increase of the diseases of civilization and their prevention","volume":"95","year":"1953","journal-title":"Munch Med Woche"},{"issue":"2","key":"10.1016\/j.jiph.2025.102840_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-8731.1000107","article-title":"Probiotics: history and evolution","volume":"1","author":"Gogineni","year":"2013","journal-title":"J Anc Dis Prev Rem"},{"key":"10.1016\/j.jiph.2025.102840_bib52","first-page":"116","article-title":"Anti-und Probiotica","volume":"25","author":"Vergin","year":"1954","journal-title":"Hipokrates"},{"key":"10.1016\/j.jiph.2025.102840_bib53","series-title":"Probiotic bacteria and enteric infections","article-title":"Probiotics: From the ancient wisdom to the actual therapeutical and nutraceutical perspective","author":"Caramia","year":"2011"},{"issue":"3659","key":"10.1016\/j.jiph.2025.102840_bib54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.147.3659.747","article-title":"Probiotics: growth-promoting factors produced by microorganisms","volume":"147","author":"Lilly","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.jiph.2025.102840_bib55","first-page":"4","article-title":"The other half of the antibiotic story","volume":"29","author":"Parker","year":"1974","journal-title":"Anim Nut Health"},{"issue":"5","key":"10.1016\/j.jiph.2025.102840_bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2672.1989.tb05105.x","article-title":"Fuller R. Probiotics in man and animals","volume":"66","year":"1989","journal-title":"J Appl Bacteriol"},{"key":"10.1016\/j.jiph.2025.102840_bib57","first-page":"1","author":"FAO\/WHO Expert Consultation","year":"2001","journal-title":"Health Nutr Prop probiotics Food Incl Powder Milk live Lact Acid Bact; FAO\/WHO: C\u00f3rdoba, Argent"},{"issue":"8","key":"10.1016\/j.jiph.2025.102840_bib58","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jiph.2025.102840_bib59","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jiph.2025.102840_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.616713","article-title":"Modulatory effects of probiotics during pathogenic infections with emphasis on immune regulation","volume":"12","author":"Raheem","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiph.2025.102840_bib61","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.fbio.2018.10.008","article-title":"Prebiotics and synbiotics: Recent concepts in nutrition","volume":"26","author":"Mohanty","year":"2018","journal-title":"Food Biosci"},{"key":"10.1016\/j.jiph.2025.102840_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2022.119066","article-title":"Probiotics, prebiotics, and synbiotics to prevent or combat air pollution consequences: The gut-lung axis","volume":"302","author":"Keulers","year":"2022","journal-title":"Environ Pollut"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12929-018-0493-6","article-title":"Probiotics, prebiotics and amelioration of diseases","volume":"26","author":"Tsai","year":"2019","journal-title":"J Biomed Sci"},{"issue":"7","key":"10.1016\/j.jiph.2025.102840_bib65","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/nu11071591","article-title":"Probiotics in food systems: Significance and emerging strategies towards improved viability and delivery of enhanced beneficial value","volume":"11","author":"Terpou","year":"2019","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.jiph.2025.102840_bib66","first-page":"13","article-title":"Application of probiotics in complex treatment of tuberculosis","volume":"4","author":"Gavrilova","year":"2014","journal-title":"Int J Eng Res Appl"},{"key":"10.1016\/j.jiph.2025.102840_bib67","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3389\/fmicb.2019.01663","article-title":"Lactobacilli isolated from wild boar (Sus scrofa) antagonize Mycobacterium bovis Bacille Calmette-Guerin (BCG) in a species-dependent manner","volume":"10","author":"Bravo","year":"2019","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3920\/BM2013.0030","article-title":"In vitro study of beneficial properties and safety of lactic acid bacteria isolated from Portuguese fermented meat products","volume":"5","author":"Todorov","year":"2014","journal-title":"Benef Microbes"},{"issue":"2","key":"10.1016\/j.jiph.2025.102840_bib69","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijantimicag.2010.03.029","article-title":"Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria","volume":"36","author":"Carroll","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jiph.2025.102840_bib70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1472-765x.2000.00840.x","article-title":"Nisin depletes ATP and proton motive force in mycobacteria","volume":"31","author":"Chung","year":"2000","journal-title":"Lett Appl Microbiol"},{"issue":"4","key":"10.1016\/j.jiph.2025.102840_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2020.01.017","article-title":"Purification and characterization of anti-tubercular and anticancer protein from Staphylococcus hominis strain MANF2: In silico structural and functional insight of peptide","volume":"27","author":"Khusro","year":"2020","journal-title":"Saudi J Biol Sci"},{"issue":"6","key":"10.1016\/j.jiph.2025.102840_bib72","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.intimp.2010.03.014","volume":"10","author":"Ghadimi","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jiph.2025.102840_bib73","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijbiomac.2022.02.005","article-title":"Beclin1-mediated interplay between autophagy and apoptosis: New understanding","volume":"204","author":"Prerna","year":"2022","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.jiph.2025.102840_bib74","first-page":"1060","article-title":"Measuring autophagosome flux","volume":"14","author":"du Toit","year":"2018","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib75","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1038\/s41598-022-12413-z","article-title":"In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota","volume":"12","author":"Rahim","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2025.102840_bib76","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s12275-021-1332-0","article-title":"Activity of Lactobacillus crispatus isolated from vaginal microbiota against Mycobacterium tuberculosis","volume":"59","author":"Lee","year":"2021","journal-title":"J Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib77","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4081\/jphia.2023.2504","article-title":"The effect of isolated probiotics from Indonesian Passiflora edulis sims. on interferon gamma levels in peripheral blood mononuclear cell of adult tuberculosis patients in vitro","volume":"14","author":"Nurrosyidah","year":"2023","journal-title":"J Public Health Afr"},{"key":"10.1016\/j.jiph.2025.102840_bib78","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2019.01142","article-title":"Gut microbiota regulates mincle mediated activation of lung dendritic cells to protect against Mycobacterium tuberculosis","volume":"10","author":"Negi","year":"2019","journal-title":"Front Immunol"},{"issue":"41","key":"10.1016\/j.jiph.2025.102840_bib79","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.1021\/acs.jpcb.4c03242","article-title":"Coarse-graining the recognition of a glycolipid by the C-type lectin Mincle receptor","volume":"128","author":"Noriega","year":"2024","journal-title":"J Phys Chem B"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01571-17","article-title":"Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular","volume":"62","author":"Negatu","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jiph.2025.102840_bib81","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/nu14081668","article-title":"Lactobacillus casei improve anti-tuberculosis drugs-induced intestinal adverse reactions in rat by modulating gut microbiota and short-chain fatty acids","volume":"14","author":"Li","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib82","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15789\/2220-7619-MEO-7223","article-title":"Microbiological evaluation of probiotic therapy in patients with pulmonary tuberculosis","volume":"13","author":"Otdushkina","year":"2023","journal-title":"Russ J Infect Immun"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib83","first-page":"66","article-title":"Lactobacillus casei modulates inflammatory cytokines and metabolites during tuberculosis treatment: A post hoc randomized controlled trial","volume":"31","author":"Jiang","year":"2022","journal-title":"Asia Pac J Clin Nutr"},{"issue":"S8","key":"10.1016\/j.jiph.2025.102840_bib84","first-page":"1283","article-title":"Synbiotic and nutrients supplement improved of Secretory Immunoglobulin A (sIgA) in treated pulmonary tuberculosis patients","volume":"23","author":"Samsidi","year":"2020","journal-title":"Ann Trop Med Public Health"},{"issue":"7","key":"10.1016\/j.jiph.2025.102840_bib85","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3923\/pjn.2016.680.685","article-title":"NS. Effect of combined probiotics and zinc supplementation on immune status of pulmonary tuberculosis patients","volume":"15","author":"Darmono","year":"2016","journal-title":"Pak J Nutr"},{"issue":"4","key":"10.1016\/j.jiph.2025.102840_bib86","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijtb.2019.11.005","article-title":"Adverse drug reactions in tuberculosis and management","volume":"66","author":"Prasad","year":"2019","journal-title":"Indian J Tube"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib87","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1039\/C9FO01583C","article-title":"Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose\u2013response trial","volume":"11","author":"Lin","year":"2020","journal-title":"Food Funct"},{"issue":"16","key":"10.1016\/j.jiph.2025.102840_bib88","article-title":"Lactobacillus casei alleviated the abnormal increase of cholestasis-related liver indices during tuberculosis treatment: a post hoc analysis of randomized controlled trial","volume":"65","author":"Xiong","year":"2021","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12896-018-0461-y","article-title":"Proof of concept in utilizing in-trans surface display system of Lactobacillus plantarum as mucosal tuberculosis vaccine via oral administration in mice","volume":"18","author":"Mustafa","year":"2018","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.jiph.2025.102840_bib90","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3389\/fimmu.2019.01588","article-title":"Inactivated Lactobacillus plantarum carrying a surface-displayed Ag85B-ESAT-6 fusion antigen as a booster vaccine against Mycobacterium tuberculosis infection","volume":"10","author":"Kuczkowska","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jiph.2025.102840_bib91","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/jam.13449","article-title":"Lactococcus lactis carrying a DNA vaccine coding for the ESAT-6 antigen increases IL-17 cytokine secretion and boosts the BCG vaccine immune response","volume":"122","author":"Pereira","year":"2017","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jiph.2025.102840_bib92","article-title":"A simple and rapid method of probiotic bacterial ghost cell preparation to deliver Mycobacterium tuberculosis antigen","author":"Aarthi","year":"2024","journal-title":"Mol Biotechnol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00284-023-03526-3","article-title":"Quality management of probiotics: Ensuring safety and maximizing health benefits","volume":"81","author":"Ahire","year":"2024","journal-title":"Curr Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib94","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2185034","article-title":"Emerging issues in probiotic safety: 2023 perspectives","volume":"15","author":"Merenstein","year":"2023","journal-title":"Gut Microbes"},{"issue":"12","key":"10.1016\/j.jiph.2025.102840_bib95","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/17425255.2020.1825682","article-title":"Antibiotic resistance propagation through probiotics","volume":"16","author":"Daniali","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102840_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00019-24","article-title":"Evaluating the health risk of probiotic supplements from the perspective of antimicrobial resistance","volume":"13","author":"Tian","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiph.2025.102840_bib97","series-title":"Probiotics as live biotherapeutics for veterinary and human health, Volume 2: Functional foods and post-genomics","first-page":"725","article-title":"Evaluation of probiotics and safety concerns. In book","author":"Singh","year":"2024"},{"issue":"10","key":"10.1016\/j.jiph.2025.102840_bib98","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/children8100924","article-title":"Invasive infections associated with the use of probiotics in children: a systematic review","volume":"8","author":"D\u2019Agostin","year":"2021","journal-title":"Children"},{"issue":"5","key":"10.1016\/j.jiph.2025.102840_bib99","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s12602-024-10247-x","article-title":"Unlocking the potential of probiotics: A comprehensive review on research, production, and regulation of probiotics","volume":"16","author":"da Silva","year":"2024","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"10","key":"10.1016\/j.jiph.2025.102840_bib100","first-page":"1027","article-title":"Analysis of the therapeutic effect of probiotics combined with enteral nutrition on patients with comorbidity of tuberculosis and type 2 diabetes with malnutrition","volume":"43","author":"Tang","year":"2021","journal-title":"Chin J Antituberc"},{"key":"10.1016\/j.jiph.2025.102840_bib101","doi-asserted-by":"crossref","DOI":"10.2174\/0126666499221169231123062539","article-title":"Tuberculosis-related mood disorders: Probiotics as a next-generation strategy","author":"Bhardwaj","year":"2024","journal-title":"Curr Probiotics"},{"key":"10.1016\/j.jiph.2025.102840_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2024.111396","article-title":"Fecal microbiota transplantation: A potential novel treatment strategy for extensively drug-resistant tuberculosis","volume":"189","author":"Nejadghaderi","year":"2024","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jiph.2025.102840_bib103","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2147\/IDR.S218638","article-title":"Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review","volume":"12","author":"Azimi","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.jiph.2025.102840_bib104","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clnu.2023.01.016","article-title":"Tuberculosis and malnutrition: the European perspective","volume":"42","author":"Ockenga","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jiph.2025.102840_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.673100","article-title":"Antituberculosis therapy and gut microbiota: review of potential host microbiota directed-therapies","volume":"11","author":"Diallo","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiph.2025.102840_bib106","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9676452","article-title":"The prospects for the therapeutic implications of genetically engineered probiotics","volume":"2020","author":"Mazhar","year":"2020","journal-title":"J Food Qual"},{"issue":"3","key":"10.1016\/j.jiph.2025.102840_bib107","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/microorganisms12030430","article-title":"Next-generation probiotics as novel therapeutics for improving human health: current trends and future perspectives","volume":"12","author":"Abouelela","year":"2024","journal-title":"Microorganisms"},{"issue":"2(2","key":"10.1016\/j.jiph.2025.102840_bib108","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125001893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125001893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T19:06:06Z","timestamp":1754075166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125001893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":108,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1876034125001893"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102840","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role of probiotics and their bioactive compounds in the management of pulmonary tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102840"}}